In the news

Press Releases

Docbot Announces Publication of UltivisionAI™ to Automatically Assess Bowel Preparation for Colonoscopy in Peer-Reviewed Journal, Gastrointestinal Endoscopy

Docbot Announces Publication of UltivisionAI™ to Automatically Assess Bowel Preparation for Colonoscopy in Peer-Reviewed Journal, Gastrointestinal Endoscopy Published in Gastrointestinal Endoscopy, Vol. 95, Issue 3 IRVINE, Calif., March 14, 2022 — Docbot, Inc., a leading developer of artificial intelligence (AI)-driven healthcare applications in gastroenterology, announced results from its study evaluating its “UltivisionAI* platform to automate…

Read More...

Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO

Total capital raised is $8.5M after $4M Series A led by Khosla Ventures, joined by Bold Capital Partners, Collaborative Fund and Boutique Venture Partners Andrew J. Ritter appointed as CEO Docbot’s UltivisionAI™ software platform uses artificial intelligence for automated gastrointestinal (GI) disease detection IRVINE, Calif.–(BUSINESS WIRE)–Docbot, Inc., an artificial intelligence (AI) technology company focusing on…

Read More...

Docbot Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021

Study establishes first continuous real-time Barrett’s esophagus dysplasia automated detection AI algorithm   May 19, 2021 08:00 AM Eastern Daylight Time   IRVINE, Calif.–(BUSINESS WIRE)–Docbot, Inc., an artificial intelligence (AI) technology company focusing on gastrointestinal (GI) disease, today announced the following upcoming oral presentation at Digestive Disease Week (DDW) 2021, which takes place virtually May…

Read More...

Docbot Announces Results of Study Evaluating Deep Learning Platform for Ulcerative Colitis Published in Journal, Gastroenterology

First to demonstrate deep learning algorithm can be trained to automatically predict levels of ulcerative colitis severity from endoscopic videos

Represents opportunity to introduce machine reading of endoscopic videos into ulcerative colitis clinical trials

Read More...

First Subjects Enrolled in Docbot’s Pivotal Study of its Ultivision™ AI Gastroenterology Imaging Platform to Detect Adenomas During Colonoscopy

Provides real-time, expert-level analyses for endoscopic procedures   IRVINE, Calif. and REDWOOD CITY, Calif., June 24, 2020 /PRNewswire/ — Docbot, Inc., a privately-held company developing leading artificial intelligence (AI)-driven healthcare applications, today announced the first subjects enrolled at Gastro Health in a pivotal trial to validate Ultivision™ AI imaging platform for adenoma detection during colonoscopy…

Read More...

Docbot Unveils Qualoscopy, Artificial Intelligence for Colonoscopy in Partnership with University of California Irvine

Innovative medical informatics company to improve colonoscopy accuracy and real-time results through AI-driven applications   NEWS PROVIDED BY Docbot Jun 04, 2018, 11:13 ET   IRVINE, Calif., June 4, 2018 /PRNewswire/ — After months of interface development and testing at the University of California Irvine (UCI), Docbot, a medical informatics company, officially announced today its…

Read More...